fig1
![MELD score and AST-to-platelet ratio index predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study](https://image.oaes.cc/d3e7d92d-b1f1-4c32-b9a2-a54f5c133a1f/2066.fig.1.png)
Figure 1. Modified overall 3-year and 5-year survival for selected patient characteristics. LT: liver transplantation; APRI: AST-to-platelet ratio index; MELD: Model for End Stage Liver Disease; Tbili: total bilirubin; Cr: creatinine; CTP: Child-Turcotte-Pugh score; Alb: albumin; HR: hepatic resection; RFA: radiofrequency ablation; DM: diabetes mellitus